What does CUSIP 04683R106 represent in this 13F holders report?

CUSIP 04683R106 is the security identifier for AVIR - Atea Pharmaceuticals, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held AVIR - Atea Pharmaceuticals, Inc. - Common Stock in Q1 2021?

78 institutional investors reported AVIR - Atea Pharmaceuticals, Inc. - Common Stock for Q1 2021. Use the holders table for investor-level position and value details.

Atea Pharmaceuticals, Inc. - Common Stock (AVIR)

CUSIP: 04683R106

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Common Stock
Shares outstanding: 78,888,889
Total 13F shares: 47,389,412
Share change: -472,503
Total reported value: $2,914,493,173
Put/Call ratio: 60%
Price per share: $61.75
Number of holders: 78
Value change: +$30,510,569
Number of buys: 40
Number of sells: 32

Quarterly Holders Quick Answers

What is CUSIP 04683R106?
CUSIP 04683R106 identifies AVIR - Atea Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 04683R106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AVIR - Atea Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	8.2%	6,447,692	$269,384,000	—	31 Dec 2020	13F
Cormorant Asset Management, LP	13F	Company	8.1%	6,411,355	$259,830,000	—	31 Dec 2020	13F
Bain Capital Life Sciences Investors, LLC	13F	Company	7.1%	5,615,659	$234,622,000	—	31 Dec 2020	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	6.8%	5,368,451	$224,294,000	—	31 Dec 2020	13F
PERCEPTIVE ADVISORS LLC	13F	Company	3.9%	3,109,224	$129,903,000	—	31 Dec 2020	13F
ABG Innovation Capital Partners III GP Ltd	13F	Company	3.3%	2,639,178	$110,265,000	—	31 Dec 2020	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	3.2%	2,517,977	$102,251,000	—	31 Dec 2020	13F
Redmile Group, LLC	13F	Company	2.8%	2,231,710	$93,241,000	—	31 Dec 2020	13F
AJU IB Investment Co., Ltd.	13F	Company	2.6%	2,049,331	$85,621,000	—	31 Dec 2020	13F
Rock Springs Capital Management LP	13F	Company	2.2%	1,697,403	$70,917,000	—	31 Dec 2020	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	2.1%	1,694,419	$70,793,000	—	31 Dec 2020	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	1.9%	1,492,090	$62,340,000	—	31 Dec 2020	13F
BlackRock Finance, Inc.	13F	Company	1.7%	1,315,830	$54,975,000	—	31 Dec 2020	13F
VANGUARD GROUP INC	13F	Company	1.4%	1,084,527	$45,312,000	—	31 Dec 2020	13F
Ally Bridge Group (NY) LLC	13F	Company	1.3%	1,016,688	$42,477,000	—	31 Dec 2020	13F
Bain Capital Public Equity Management II, LLC	13F	Company	1.4%	1,097,208	$42,302,000	—	31 Dec 2020	13F
Omega Fund Management, LLC	13F	Company	1.1%	847,208	$35,396,000	—	31 Dec 2020	13F
Fan Yu	13F	Individual	0.38%	300,000	$12,534,000	—	31 Dec 2020	13F
Woodline Partners LP	13F	Company	0.35%	276,083	$11,535,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.34%	267,866	$11,191,000	—	31 Dec 2020	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.33%	258,285	$10,791,000	—	31 Dec 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.31%	243,641	$10,179,000	—	31 Dec 2020	13F
STATE STREET CORP	13F	Company	0.28%	222,674	$9,303,000	—	31 Dec 2020	13F
NORTHERN TRUST CORP	13F	Company	0.22%	176,905	$7,391,000	—	31 Dec 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.21%	168,205	$7,028,000	—	31 Dec 2020	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.19%	152,504	$6,372,000	—	31 Dec 2020	13F
HHLR ADVISORS, LTD.	13F	Company	0.16%	125,000	$5,223,000	—	31 Dec 2020	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.14%	111,176	$4,645,000	—	31 Dec 2020	13F
MORGAN STANLEY	13F	Company	0.14%	106,587	$4,453,000	—	31 Dec 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.11%	86,434	$3,612,000	—	31 Dec 2020	13F
Alyeska Investment Group, L.P.	13F	Company	0.1%	75,000	$3,134,000	—	31 Dec 2020	13F
CAAS CAPITAL MANAGEMENT LP	13F	Company	0.09%	70,000	$2,925,000	—	31 Dec 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.07%	53,091	$2,219,000	—	31 Dec 2020	13F
Laurion Capital Management LP	13F	Company	0.06%	45,000	$1,880,000	—	31 Dec 2020	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.05%	42,715	$1,784,000	—	31 Dec 2020	13F
Marshall Wace North America L.P.	13F	Company	0.05%	42,002	$1,755,000	—	31 Dec 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.05%	39,126	$1,634,000	—	31 Dec 2020	13F
ETF MANAGERS GROUP, LLC	13F	Company	0.05%	38,543	$1,608,000	—	31 Dec 2020	13F
Bank of New York Mellon Corp	13F	Company	0.05%	36,819	$1,538,000	—	31 Dec 2020	13F
Legal & General Group Plc	13F	Company	0.04%	33,330	$1,394,000	—	31 Dec 2020	13F
CONGRESS ASSET MANAGEMENT CO	13F	Company	0.04%	33,010	$1,379,000	—	31 Dec 2020	13F
NORGES BANK	13F	Company	0.04%	30,000	$1,253,000	—	31 Dec 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.04%	28,472	$1,190,000	—	31 Dec 2020	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.03%	21,934	$916,000	—	31 Dec 2020	13F
TD ASSET MANAGEMENT INC	13F	Company	0.03%	20,687	$864,000	—	31 Dec 2020	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.03%	20,100	$840,000	—	31 Dec 2020	13F
Athanor Capital, LP	13F	Company	0.02%	16,896	$706,000	—	31 Dec 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.02%	14,192	$593,000	—	31 Dec 2020	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.02%	12,700	$531,000	—	31 Dec 2020	13F
RHUMBLINE ADVISERS	13F	Company	0.02%	12,516	$523,000	—	31 Dec 2020	13F

Institutional Holders of Atea Pharmaceuticals, Inc. - Common Stock (AVIR) as of Q1 2021

As of 31 Mar 2021, Atea Pharmaceuticals, Inc. - Common Stock (AVIR) was held by 78 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 47,389,412 shares. The largest 10 holders included FMR LLC, Cormorant Asset Management, LP, Bain Capital Life Sciences Investors, LLC, RA CAPITAL MANAGEMENT, L.P., PERCEPTIVE ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, Rock Springs Capital Management LP, ADAGE CAPITAL PARTNERS GP, L.L.C., Sectoral Asset Management Inc, and Redmile Group, LLC. This page lists 79 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

Q1 2021 holders

Holder diff

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.